BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 12737635)

  • 1. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D.
    Walters SJ; Brazier JE
    Health Qual Life Outcomes; 2003 Apr; 1():4. PubMed ID: 12737635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.
    Walters SJ; Brazier JE
    Qual Life Res; 2005 Aug; 14(6):1523-32. PubMed ID: 16110932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse.
    Harvie HS; Honeycutt AA; Neuwahl SJ; Barber MD; Richter HE; Visco AG; Sung VW; Shepherd JP; Rogers RG; Jakus-Waldman S; Mazloomdoost D;
    Am J Obstet Gynecol; 2019 Mar; 220(3):265.e1-265.e11. PubMed ID: 30471259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis.
    Khanna D; Furst DE; Wong WK; Tsevat J; Clements PJ; Park GS; Postlethwaite AE; Ahmed M; Ginsburg S; Hays RD;
    Qual Life Res; 2007 Aug; 16(6):1083-92. PubMed ID: 17404896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity, responsiveness, and minimal important difference for the SF-6D health utility scale in a spinal cord injured population.
    Lee BB; King MT; Simpson JM; Haran MJ; Stockler MR; Marial O; Salkeld G
    Value Health; 2008; 11(4):680-8. PubMed ID: 18194406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke.
    Kim SK; Kim SH; Jo MW; Lee SI
    Health Qual Life Outcomes; 2015 Mar; 13():32. PubMed ID: 25889191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SF-6D utility index as measure of minimally important difference in health status change.
    Gandhi PK; Ried LD; Bibbey A; Huang IC
    J Am Pharm Assoc (2003); 2012; 52(1):34-42. PubMed ID: 22257614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the Performance of 2 Health Utility Measures in the Medicare Health Outcome Survey (HOS).
    Jia H; Lubetkin EI; DeMichele K; Stark DS; Zack MM; Thompson WW
    Med Decis Making; 2018 Nov; 38(8):983-993. PubMed ID: 30403580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SF-6D values stratified by specific diagnostic indication.
    Carreon LY; Djurasovic M; Canan CE; Burke LO; Glassman SD
    Spine (Phila Pa 1976); 2012 Jun; 37(13):E804-8. PubMed ID: 22228327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis.
    Kwakkenbos L; Fransen J; Vonk MC; Becker ES; Jeurissen M; van den Hoogen FH; van den Ende CH
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):50-6. PubMed ID: 23910610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in cochlear implantees: comparing utility values obtained through the Medical Outcome Study Short-Form Survey-6D and the Health Utility Index Mark 3.
    Arnoldner C; Lin VY; Bresler R; Kaider A; Kuthubutheen J; Shipp D; Chen JM
    Laryngoscope; 2014 Nov; 124(11):2586-90. PubMed ID: 24536018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SF-6D health utility index in carpal tunnel syndrome.
    Atroshi I; Gummesson C; McCabe SJ; Ornstein E
    J Hand Surg Eur Vol; 2007 Apr; 32(2):198-202. PubMed ID: 17223234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SF-6D utility scores of smokers and ex-smokers with or without respiratory symptoms attending primary care clinics.
    Fu SN; Dao MC; Wong CK; Yu WC
    Health Qual Life Outcomes; 2019 Mar; 17(1):48. PubMed ID: 30876466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.
    Gaujoux-Viala C; Rat AC; Guillemin F; Flipo RM; Fardellone P; Bourgeois P; Fautrel B
    J Rheumatol; 2011 Aug; 38(8):1576-84. PubMed ID: 21532054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease.
    van Stel HF; Buskens E
    Health Qual Life Outcomes; 2006 Mar; 4():20. PubMed ID: 16563170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life and General Health After Elective Surgery for Cervical Spine Pathologies: Determining a Valid and Responsive Metric of Health State Utility.
    Chotai S; Parker SL; Sivaganesan A; Godil SS; McGirt MJ; Devin CJ
    Neurosurgery; 2015 Oct; 77(4):553-60; discussion 560. PubMed ID: 26191977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internal Consistency of the SF-6D as a Health Status Index in the Brazilian Urban Population.
    Campolina AG; López RVM; Nardi EP; Ferraz MB
    Value Health Reg Issues; 2018 Dec; 17():74-80. PubMed ID: 29747071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.